JP2004511469A5 - - Google Patents

Download PDF

Info

Publication number
JP2004511469A5
JP2004511469A5 JP2002534293A JP2002534293A JP2004511469A5 JP 2004511469 A5 JP2004511469 A5 JP 2004511469A5 JP 2002534293 A JP2002534293 A JP 2002534293A JP 2002534293 A JP2002534293 A JP 2002534293A JP 2004511469 A5 JP2004511469 A5 JP 2004511469A5
Authority
JP
Japan
Prior art keywords
alkyl
substituted
methyl
substituents
alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002534293A
Other languages
English (en)
Japanese (ja)
Other versions
JP4015548B2 (ja
JP2004511469A (ja
Filing date
Publication date
Priority claimed from GBGB0024795.7A external-priority patent/GB0024795D0/en
Application filed filed Critical
Publication of JP2004511469A publication Critical patent/JP2004511469A/ja
Publication of JP2004511469A5 publication Critical patent/JP2004511469A5/ja
Application granted granted Critical
Publication of JP4015548B2 publication Critical patent/JP4015548B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002534293A 2000-10-10 2001-10-04 ウイルス性疾患の処置のためのピラゾール誘導体 Expired - Fee Related JP4015548B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0024795.7A GB0024795D0 (en) 2000-10-10 2000-10-10 Pyrazole derivatives for the treatment of viral diseases
PCT/EP2001/011474 WO2002030907A1 (en) 2000-10-10 2001-10-04 Pyrazole derivatives for the treatment of viral diseases

Publications (3)

Publication Number Publication Date
JP2004511469A JP2004511469A (ja) 2004-04-15
JP2004511469A5 true JP2004511469A5 (enExample) 2005-04-14
JP4015548B2 JP4015548B2 (ja) 2007-11-28

Family

ID=9900999

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002534293A Expired - Fee Related JP4015548B2 (ja) 2000-10-10 2001-10-04 ウイルス性疾患の処置のためのピラゾール誘導体

Country Status (28)

Country Link
US (2) US6699887B2 (enExample)
EP (1) EP1326843A1 (enExample)
JP (1) JP4015548B2 (enExample)
KR (1) KR100534158B1 (enExample)
CN (2) CN1680333A (enExample)
AR (1) AR030858A1 (enExample)
AU (2) AU2002221651B2 (enExample)
BR (1) BR0114483A (enExample)
CA (1) CA2423515A1 (enExample)
CZ (1) CZ20031297A3 (enExample)
EC (1) ECSP034547A (enExample)
GB (1) GB0024795D0 (enExample)
GT (1) GT200100201A (enExample)
HR (1) HRP20030251A2 (enExample)
HU (1) HUP0302722A2 (enExample)
IL (1) IL154875A0 (enExample)
MA (1) MA26951A1 (enExample)
MX (1) MXPA03003070A (enExample)
NO (1) NO20031615L (enExample)
NZ (1) NZ524740A (enExample)
PA (1) PA8530301A1 (enExample)
PE (1) PE20020750A1 (enExample)
PL (1) PL362918A1 (enExample)
RU (1) RU2270832C2 (enExample)
UY (1) UY26956A1 (enExample)
WO (1) WO2002030907A1 (enExample)
YU (1) YU27203A (enExample)
ZA (1) ZA200302519B (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2083005A1 (en) * 2000-09-29 2009-07-29 TopoTarget UK Limited Carbamic acid compounds comprising an amide linkage as HDAC inhibitors
GB0113524D0 (en) 2001-06-04 2001-07-25 Hoffmann La Roche Pyrazole derivatives
CA2495338A1 (en) 2002-09-26 2004-04-08 Pfizer Inc. Pyrazole amides for treating hiv infections
US7230025B2 (en) 2002-09-26 2007-06-12 Pfizer, Inc. Pyrazole derivatives
EP1546132A1 (en) * 2002-09-26 2005-06-29 Pfizer Limited Pyrazole derivatives as reverse transcriptase inhibitors
GB0223234D0 (en) * 2002-10-07 2002-11-13 Pfizer Ltd Chemical compounds
GB0223232D0 (en) * 2002-10-07 2002-11-13 Pfizer Ltd Chemical compounds
US6933312B2 (en) 2002-10-07 2005-08-23 Agouron Pharmaceuticals, Inc. Pyrazole derivatives
TW200423930A (en) * 2003-02-18 2004-11-16 Hoffmann La Roche Non-nucleoside reverse transcriptase inhibitors
MXPA05010081A (es) 2003-03-24 2005-11-23 Hoffmann La Roche Bencil-piridazinonas como inhibidores de transcriptasa inversa.
US7220772B2 (en) 2003-09-05 2007-05-22 Pfizer, Inc. Pyrazole derivatives
DK1775298T3 (da) * 2004-07-01 2013-05-21 Daiichi Sankyo Co Ltd Thienopyrazolderivat med PDE7-inhibitorisk aktivitet
US20070005049A1 (en) * 2005-06-30 2007-01-04 Comben Richard H Apparatus and Method of Treating Urinary Incontinence by Heating Urethra
NZ574207A (en) * 2006-07-05 2010-10-29 Pfizer Prod Inc Pyrazole derivatives as cytochrome p450 inhibitors
AU2007286345B2 (en) 2006-08-16 2012-03-08 F. Hoffmann-La Roche Ag Non-nucleoside reverse transcriptase inhibitors
GB0713479D0 (en) * 2007-07-11 2007-08-22 Syngenta Participations Ag Substituted aromatic heterocyclic compounds as fungicides
JP5411160B2 (ja) 2007-12-21 2014-02-12 エフ.ホフマン−ラ ロシュ アーゲー 複素環式抗ウイルス性化合物
GB0823000D0 (en) * 2008-12-17 2009-01-28 Syngenta Participations Ag Isothiazole and pyrazole derivatives with plant growth regulating properties
CN102333781B (zh) 2009-02-25 2014-06-11 第一三共株式会社 三环吡唑并嘧啶衍生物
FR2951549B1 (fr) 2009-10-15 2013-08-23 Olivier Schussler Procede d'obtention de bioprotheses medicales implantables
WO2012026433A1 (ja) 2010-08-23 2012-03-01 第一三共株式会社 三環性ピラゾロピリミジン誘導体のフリー体結晶
WO2012026434A1 (ja) 2010-08-23 2012-03-01 第一三共株式会社 三環性ピラゾロピリミジン誘導体の結晶
US9695127B2 (en) 2012-11-08 2017-07-04 University of Pittsburgh—of the Commonwealth System of Higher Education Compounds for treating HIV and methods for using the compounds
US9925190B2 (en) 2015-02-16 2018-03-27 University of Pittsburgh—of the Commonwealth System of Higher Education Small molecules targeting HIV-1 Nef
JP7301042B2 (ja) 2018-03-30 2023-06-30 住友化学株式会社 複素環化合物及びそれを含有する有害節足動物防除組成物
US20220380341A1 (en) * 2018-10-18 2022-12-01 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Inhibitors of hiv-1 nef for the treatment of hiv disease
FR3121927B1 (fr) 2021-04-19 2023-03-31 Eiffage Genie Civil Terrassement Procédé d’inertage des boues d’excavation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993015060A1 (fr) 1992-01-22 1993-08-05 Nissan Chemical Industries, Ltd. Derive de pyrazole substitue et bactericide agrohorticole
RU2130453C1 (ru) * 1992-12-17 1999-05-20 Пфайзер Инк. Замещенные пиразолы, фармацевтическая композиция на их основе, способ лечения, промежуточный продукт
TW336932B (en) * 1992-12-17 1998-07-21 Pfizer Amino-substituted pyrazoles
JP2862374B2 (ja) * 1992-12-17 1999-03-03 フアイザー・インコーポレイテツド Crfアンタゴニスト活性を有するピラゾール及びピラゾロピリミジン
US6005109A (en) 1997-10-30 1999-12-21 Pflizer Inc. Pyrazoles and pyrazolopyrimidines having CRF antagonistic activity
WO2006027423A1 (fr) * 2004-08-09 2006-03-16 Simag Developpement Dispositif de saisie comportant un capteur optique suivi d’un moyen de filtrage

Similar Documents

Publication Publication Date Title
JP2004511469A5 (enExample)
RU2003112610A (ru) Производные пиразола для лечения вирксных заболеваний
JP2021119196A5 (enExample)
JP2018535999A5 (enExample)
JP2010505809A5 (enExample)
JP2014526500A5 (enExample)
JP2004504301A5 (enExample)
JP2014526501A5 (enExample)
JP2012528847A5 (enExample)
RU2019118623A (ru) Пирролопиримидины в качестве потенциаторов мвтр
JP2020521730A5 (enExample)
JP2008513514A5 (enExample)
JP2010533158A5 (enExample)
RU99126510A (ru) 3(5)-гетероарилзамещенные пиразолы в качестве ингибиторов киназы p38
NZ609955A (en) Sgc stimulators
JP2009536196A5 (enExample)
JP2010502615A5 (enExample)
JP2012525349A5 (enExample)
RU2008141509A (ru) Mglur5 модуляторы 1
RU2010116352A (ru) Производные 1,1,1-трифтор-2-гидрокси-3-фенилпропана
JP2014524461A5 (enExample)
RU2019132212A (ru) Селективные ингибиторы hdac6
JP2018534328A5 (enExample)
JP2013531070A5 (enExample)
JP2020520357A5 (enExample)